.svg)
Quebec provides coverage for continuous glucose monitoring (CGM) and flash glucose monitoring systems through the Régie de l'assurance maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan. Coverage is available for eligible Quebec residents with diabetes who meet the program requirements. In November 2025, Quebec expanded Dexcom CGM coverage to include adults with Type 2 diabetes on intensive insulin therapy, building on existing coverage for Type 1 diabetes.
To learn more about which CGM systems are available across Canada, visit Our Guide to Continuous Glucose Monitors in Canada.
RAMQ provides CGM coverage for Quebec residents with diabetes who meet age-specific and clinical eligibility requirements. Eligibility criteria vary by device.
Dexcom G6 and G7
For children and youth ages 2 to 17 years: You must have Type 1 diabetes.
For adults 18 years of age and older: You must be treated with intensive insulin therapy and meet at least one of the following clinical criteria:
FreeStyle Libre 2
For children and youth ages 4 to 17 years: You must have Type 1 diabetes.
For adults 18 years of age and older: You must have Type 1 or Type 2 diabetes and be treated with intensive insulin therapy. You must also meet at least one of the following clinical criteria:
Intensive insulin therapy is defined as treatment with an insulin pump OR three or more insulin injections per day.
You must be a Quebec resident enrolled in the RAMQ Public Prescription Drug Insurance Plan.
RAMQ covers continuous glucose monitoring systems (CGMs) that provide real-time glucose readings and flash glucose monitoring systems.
Currently covered systems include:
These devices meet Health Canada safety standards and are appropriate for people with diabetes who use insulin therapy. FreeStyle Libre 3 and Libre 3 Plus are not currently covered by RAMQ but may be available through private insurance. Medtronic Guardian sensors are also not listed in RAMQ's public coverage.
What RAMQ funds:
What RAMQ does not cover:
The FreeStyle Libre 2 reader is provided free of charge by your pharmacist, as the manufacturer provides them at no cost.
👉 For the most current information about covered devices and eligibility criteria, visit the RAMQ website or contact RAMQ at 1-800-561-9749.
The application process requires a prescription from your healthcare provider and completion of an Exceptional Medication Form.
Step 1: Speak with your healthcare provider
Tell your physician or pharmacist that you would like to receive a prescription for a CGM system. Your healthcare provider will assess whether you meet the eligibility criteria for RAMQ coverage.
Step 2: Complete the Exceptional Medication Form
Your physician or pharmacist will complete an Exceptional Medication Form and submit it to RAMQ for approval. This form documents that you meet the clinical eligibility requirements for CGM coverage.
Step 3: Wait for approval RAMQ will review your application
Initial approval is typically granted for a six-month period to determine if CGM is suitable for your diabetes management.
Step 4: Purchase your CGM at a pharmacy
Once approved, you can purchase your CGM sensors and supplies at your local pharmacy. Your pharmacist will process your claim through RAMQ according to the Public Prescription Drug Insurance Plan.
After the initial six-month period, requests for continuation of treatment are authorized for up to 12 months at a time. To qualify for renewal, you must demonstrate optimal use of your CGM system, defined as wearing the sensor at least 70% of the time. An annual clinical reassessment by your prescriber is recommended. Follow up with your healthcare provider before your coverage period ends to ensure uninterrupted access to CGM supplies.
You are generally eligible for the Public Prescription Drug Insurance Plan if you:
When you purchase CGM sensors covered under the public plan, you pay a portion of the cost:
The reader for FreeStyle Libre systems is provided free of charge by your pharmacist, as the manufacturer provides them at no cost. You should never be charged for a reader at your pharmacy.
If you do not meet RAMQ eligibility criteria, there are other ways to access CGM technology.
Private insurance: All private insurance plans in Quebec must provide coverage that is at least equivalent to RAMQ criteria. Most private insurance plans offer broader coverage for CGM systems, including coverage for anyone with diabetes who uses insulin, and some plans cover anyone with diabetes regardless of treatment. Check with your insurance provider for specific coverage details.
Out-of-pocket costs: You can purchase CGM systems directly without insurance. Costs vary by device and usually include the transmitter and reader if needed, plus ongoing sensor costs that generally range from $250 to $400 per month.
Managing your supplies and staying connected with your diabetes care team is important for safe and effective CGM use. The Endor Health app supports ongoing communication with your care team so questions about your CGM data or therapy can be addressed promptly. The app also provides convenient home delivery of insulin, prescription items, and CGM sensors at no added cost, helping reduce the risk of missed refills or last minute pharmacy visits.
The information in this article is for educational purposes only and should not replace advice from your healthcare provider. Always consult with your diabetes care team before making changes to your diabetes management.
